Home LiteratureArticle Details
PMID: 20204471 Published · ppublish English Evaluation Study Journal Article Research Support, Non-U.S. Gov't

Critical evaluation of Nanoparticle Tracking Analysis (NTA) by NanoSight for the measurement of nanoparticles and protein aggregates.

Pharmaceutical research ·Vol. 27 ·No. 5 ·2010-05-00 ·Pages 796-810

Filipe V, Hawe A, Jiskoot W

Abstract

To evaluate the nanoparticle tracking analysis (NTA) technique, compare it with dynamic light scattering (DLS) and test its performance in characterizing drug delivery nanoparticles and protein aggregates. Standard polystyrene beads of sizes ranging from 60 to 1,000 nm and physical mixtures thereof were analyzed with NTA and DLS. The influence of different ratios of particle populations was tested. Drug delivery nanoparticles and protein aggregates were analyzed by NTA and DLS. Live monitoring of heat-induced protein aggregation was performed with NTA. NTA was shown to accurately analyze the size distribution of monodisperse and polydisperse samples. Sample visualization and individual particle tracking are features that enable a thorough size distribution analysis. The presence of small amounts of large (1,000 nm) particles generally does not compromise the accuracy of NTA measurements, and a broad range of population ratios can easily be detected and accurately sized. NTA proved to be suitable to characterize drug delivery nanoparticles and protein aggregates, complementing DLS. Live monitoring of heat-induced protein aggregation provides information about aggregation kinetics and size of submicron aggregates. NTA is a powerful characterization technique that complements DLS and is particularly valuable for analyzing polydisperse nanosized particles and protein aggregates.

MeSH Terms
Algorithms Drug Delivery Systems Excipients/chemistry Immunoglobulin G/chemistry Light Nanoparticles/analysis Nanotechnology/instrumentation Particle Size Polystyrenes/chemistry Proteins/chemistry Scattering, Radiation Software Viscosity
Chemicals
Excipients Immunoglobulin G Polystyrenes Proteins
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Filipe Vasco
Division of Drug Delivery Technology, Leiden/Amsterdam Center for Drug Research, Leiden University, P.O. Box 9502, 2300, RA, Leiden, The Netherlands.
Hawe Andrea
Jiskoot Wim
References (17)
17 references, click to expand
  1. Insulin association in neutral solutions studied by light scattering.
    Biophys Chem. 1991 Feb;39(2):205-13 PMID: 17014767
  2. Bioequivalence and the immunogenicity of biopharmaceuticals.
    Nat Rev Drug Discov. 2002 Jun;1(6):457-62 PMID: 12119747
  3. Induction and analysis of aggregates in a liquid IgG1-antibody formulation.
    Eur J Pharm Biopharm. 2005 Apr;59(3):407-17 PMID: 15760721
  4. Immunological risk of injectable drug delivery systems.
    Pharm Res. 2009 Jun;26(6):1303-14 PMID: 19247815
  5. Protein aggregation and bioprocessing.
    AAPS J. 2006;8(3):E572-9 PMID: 17025275
  6. A critical review of methods for size characterization of non-particulate protein aggregates.
    Curr Pharm Biotechnol. 2009 Jun;10(4):359-72 PMID: 19519411
  7. Macromolecular size-and-shape distributions by sedimentation velocity analytical ultracentrifugation.
    Biophys J. 2006 Jun 15;90(12):4651-61 PMID: 16565040
  8. Response of a concentrated monoclonal antibody formulation to high shear.
    Biotechnol Bioeng. 2009 Aug 1;103(5):936-43 PMID: 19370772
  9. Protein drug stability: a formulation challenge.
    Nat Rev Drug Discov. 2005 Apr;4(4):298-306 PMID: 15803194
  10. Overlooking subvisible particles in therapeutic protein products: gaps that may compromise product quality.
    J Pharm Sci. 2009 Apr;98(4):1201-5 PMID: 18704929
  11. Mechanistic study of the adjuvant effect of biodegradable nanoparticles in mucosal vaccination.
    J Control Release. 2009 Sep 1;138(2):113-21 PMID: 19445980
  12. Revisiting the method of cumulants for the analysis of dynamic light-scattering data.
    Appl Opt. 2001 Aug 20;40(24):4087-91 PMID: 18360445
  13. Emerging trends in oral delivery of peptide and protein drugs.
    Crit Rev Ther Drug Carrier Syst. 2003;20(2-3):153-214 PMID: 14584523
  14. Protein aggregation: pathways, induction factors and analysis.
    J Pharm Sci. 2009 Sep;98(9):2909-34 PMID: 18823031
  15. Comparison of scanning electron microscopy, dynamic light scattering and analytical ultracentrifugation for the sizing of poly(butyl cyanoacrylate) nanoparticles.
    Eur J Pharm Biopharm. 2004 Mar;57(2):369-75 PMID: 15018998
  16. Asymmetrical flow field-flow fractionation and multiangle light scattering for analysis of gelatin nanoparticle drug carrier systems.
    Anal Chem. 2004 Apr 1;76(7):1909-20 PMID: 15053651
  17. Drug-like properties and the causes of poor solubility and poor permeability.
    J Pharmacol Toxicol Methods. 2000 Jul-Aug;44(1):235-49 PMID: 11274893
Article Info
Journal
Pharmaceutical research
Abbr.
Pharm Res
ISSN
1573-904X
Published
2010-05-00
Epub
2010-00-04
Pages
796-810
Language
English
Region
United States
NLM ID
8406521
PMCID
PMC2852530
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com